The use of monoclonal antibodies against primary myeloid granules in normal and leukemic cells.
Three monoclonal antibodies, K101, D46, and H36/71 (CD15), reactive with membrane components of primary granules of human promyelocytes, were studied to assess their binding to normal and leukemic cells. Using the alkaline phosphatase antialkaline phosphatase technique, these antibodies were applied to sections of normal organs and to peripheral blood and bone marrow films from hematologically normal individuals and patients with hematologic malignancies. In control experiments, antibodies showed reactivity with cytoplasmic constituents of granulocytes from the promyelocytic to the neutrophilic stage. In acute myeloid leukemia, antibody K101 was positive (more than 20% of blasts) in 13 of 21 (62%) cases, while antibody D46 was positive in 11 of 17 (65%) cases. Antibody H36/71 was positive in only 4 of 24 (17%) cases of acute myeloid leukemia. At least one marker was present in 6 of 8 (75%) cases of acute lymphoblastic leukemia with myeloid antigen-positive blasts and was negative in 20 cases of acute lymphoblastic leukemia with myeloid antigen-negative blasts. These results support the view that abnormal granules (with defective expression of the D46, K101, and H36/71 antigens) form in blastic and leukemic cells of patients with acute myeloid leukemia. Data also suggest that membrane components of myeloid granules are made in the cytoplasm of cells from some acute lymphoblastic leukemia patients with myeloid antigen-positive blasts.
Elghetany
M T
MT
Department of Pathology, SUNY Health Science Center, Syracuse 13210.
Sullivan
A K
AK
Kurec
A S
AS
MacCallum
J M
JM
Bloomfield
C D
CD
Sobol
R E
RE
Davey
F R
FR
D000911:Antibodies, Monoclonal / Q000032:analysis* / Q000378:metabolism; D001853:Bone Marrow / Q000737:chemistry / Q000473:pathology* / Q000648:ultrastructure; D003594:Cytoplasmic Granules / Q000737:chemistry / Q000378:metabolism / Q000648:ultrastructure*; D005434:Flow Cytometry; D006098:Granulocytes / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D006410:Hematopoiesis; D006801:Humans; D007124:Immunoenzyme Techniques; D007150:Immunohistochemistry; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000378:metabolism / Q000473:pathology*; D007951:Leukemia, Myeloid / Q000378:metabolism / Q000473:pathology*; D008198:Lymph Nodes / Q000737:chemistry / Q000473:pathology / Q000648:ultrastructure; D009504:Neutrophils / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000378:metabolism / Q000473:pathology*; D012867:Skin / Q000737:chemistry / Q000473:pathology / Q000648:ultrastructure; D013154:Spleen / Q000737:chemistry / Q000473:pathology / Q000648:ultrastructure
D000911:Antibodies, Monoclonal